Expert Opinion on Therapeutic Patents, 1354-3776

Journal

Related Publications
  1. An updated patent review on P-glycoprotein inhibitors (2011-2018).

    Leopoldo, M., Nardulli, P., Contino, M., Leonetti, F., Luurtsema, G. & Colabufo, N. A., 3-Jun-2019, In : Expert Opinion on Therapeutic Patents. 29, 6, p. 455-461 7 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. A patent review on PD-1/PD-L1 antagonists: small molecules, peptides, and macrocycles (2015-2018)

    Shaabani, S., Huizinga, H. P. S., Butera, R., Kouchi, A., Guzik, K., Magiera-Mularz, K., Holak, T. A. & Domling, A., 2018, In : Expert Opinion on Therapeutic Patents. 28, 9, p. 665-678 14 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Inhibitors of programmed cell death 1 (PD-1): a patent review (2010-2015)

    Zarganes-Tzitzikas, T., Konstantinidou, M., Gao, Y., Krzemien, D., Zak, K., Dubin, G., Holak, T. A. & Dömling, A., Sep-2016, In : Expert Opinion on Therapeutic Patents. 26, 9, p. 973-977 5 p.

    Research output: Contribution to journalEditorialAcademicpeer-review

  4. Mdm2 and MdmX inhibitors for the treatment of cancer: a patent review (2011-present)

    Zak, K., Pecak, A., Rys, B., Wladyka, B., Doemling, A., Weber, L., Holak, T. A. & Dubin, G., Apr-2013, In : Expert Opinion on Therapeutic Patents. 23, 4, p. 425-448 24 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

  5. Sulfonamide derivatives with protease inhibitory action as anticancer, anti-inflammatory and antiviral agents

    Casini, A., Scozzafava, A. & Supuran, CT., Sep-2002, In : Expert Opinion on Therapeutic Patents. 12, 9, p. 1307-1327 21 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

View all (5) »

ID: 14926199